Glutathione is actually a tripeptide (L-gamma-glutamyl-L-cysteinyl-glycine) comprised of glutamate, cysteine, and glycine
Nausea management through meals Nausea is the most common GLP-1 side effect, affecting up to 40% of users at some point during treatment
However, their effectiveness in helping patients lose weight has led to widespread medical use for non-diabetic weight management
Tirzepatide works similarly to semaglutide but targets both GLP-1 and GIP receptors, which can lead to even greater average weight loss in studies (up to 20-21%) when combined with lifestyle changes
The broader TRIUMPH clinical trial program has enrolled more than 5,800 participants across studies examining retatrutide for obesity, overweight, obstructive sleep apnea, knee osteoarthritis, chronic low back pain, cardiovascular and renal outcomes, and metabolic dysfunction-associated steatotic liver disease
doi:10.1056/NEJMoa1607141 Lau J, Bloch P, Schffer L, et al